Typha pollen extract inhibit melanogenesis via α-MSH/MC1R signaling pathway in B16 and melasma mouse model

Shiqian Zheng1, Rongrong Deng1, Shengjun Xie2

  • 1Guangdong Botanical Beauty Care Biotechnology Co., Ltd, Guangzhou, China.

PubMed

Insights

Typha Pollen extract effectively inhibits melanin production and key proteins in the α-MSH/MC1R signaling pathway. This natural extract shows potential as a safe and effective skin whitening agent.

Area of Science:

  • Dermatology
  • Cosmetic Science
  • Pharmacology

Background:

  • Melanogenesis is a complex process regulated by signaling pathways.
  • Hyperpigmentation disorders like melasma are a significant concern.
  • Natural compounds are increasingly explored for cosmetic applications.

Purpose of the Study:

  • To evaluate the effects of Typha Pollen (TP) extract on melanogenesis.
  • To assess TP extract's efficacy in B16 melanoma cells and a melasma mouse model.
  • To investigate TP extract's impact on key regulatory proteins and enzymes involved in melanin synthesis.

Main Methods:

  • Cell viability was assessed using MTT assay.
  • Melanin content was quantified using the NaOH method.
  • Protein levels (MC1R, MITF) were measured by ELISA and immunofluorescence staining.
  • Tyrosinase (TYR) activity was determined via dopa oxidation assay.

Main Results:

  • TP extract did not affect B16 cell viability at appropriate concentrations.
  • TP extract significantly inhibited melanin production in B16 cells.
  • TP extract reduced MC1R content and TYR activity in both B16 cells and the melasma model.
  • TP extract decreased MITF content in the melasma mouse model.

Conclusions:

  • Typha Pollen extract effectively inhibits melanogenesis by targeting the α-MSH/MC1R signaling pathway.
  • TP extract reduces melanin synthesis, MC1R, MITF, and TYR activity.
  • TP extract is a promising natural ingredient for skin whitening applications.